MUCPHARM

mucpharm-logo

Clinical stage bio-pharma company focused on the treatment of mucin-containing and secreting cancers. Bromelain and acetylcysteine, BromAcâ„¢, is a patented combination drug developed by our team for mucinous cancers, where the drug affects glycosidic linkages and disulphide bonds in glycoproteins including mucinous tumours. Bromelain is an enzyme extracted from pineapple stem or fruit (ananas comosus) and it is made up of a number of enzymes (proteases, carbohydrases, phosphatases, peroxidases,... etc.) that gives it unique enzymatic properties for the hydrolysis of glycosidic bonds in complex carbohydrates. As a therapeutic molecule, it is currently used as a mucolytic in combination with acetylcysteine with anticancer properties for the treatment of mucinous tumours. It combines synergistically with a variety of anticancer drugs.

#SimilarOrganizations #People #Financial #Website #More

MUCPHARM

Industry:
Biopharma Biotechnology Life Science Pharmaceutical Therapeutics

Founded:
2016-01-01

Address:
Kogarah, New South Wales, Australia

Country:
Australia

Website Url:
http://www.mucpharm.com

Total Employee:
11+

Status:
Active

Contact:
+61 2 9113 2070

Email Addresses:
[email protected]

Total Funding:
6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics


Similar Organizations

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Employees Featured

not_available_image

Myer Herszberg
Myer Herszberg Chairman and Founder @ Mucpharm
Chairman and Founder

not_available_image

Sarah Valle
Sarah Valle Chief Development Officer and Co-founder @ Mucpharm
Chief Development Officer and Co-founder

david-morris_image

David Morris
David Morris CEO, Chief Medical Officer, Founder and Surgical Oncologist @ Mucpharm
CEO, Chief Medical Officer, Founder and Surgical Oncologist

Founder


david-morris_image

David Morris

not_available_image

Myer Herszberg

not_available_image

Sarah Valle

Investors List

herzberg-family-office_image

Herzberg Family Office

Herzberg Family Office investment in Seed Round - Mucpharm

Official Site Inspections

http://www.mucpharm.com Semrush global rank: 8.15 M Semrush visits lastest month: 359

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Mucpharm" on Search Engine